Topical administration

2 trials

Sponsors

Kaneda Mari

Conditions

Neurofibromatosis type 1 Neurofibromatosis type 1Vascular abnormality Vascular abnormality

Phase 2

A pilot study with sirolimus-gel for vascular abnormality

Active, not recruitingJPRN-jRCTs051190032

Kaneda MariVascular abnormality Vascular abnormality

Start: 2019-07-22Target: 10Updated: 2026-06-29

Phase 3

A Double-Blind Study to Evaluate Efficacy and Safety of NPC-12G in Patients with Neurofibromatosis type 1

Active, not recruitingJPRN-jRCT2051190008

Kaneda MariNeurofibromatosis type 1 Neurofibromatosis type 1

Start: 2019-05-22Target: 63Updated: 2026-06-29